Lesotho vs Myanmar: Incidence of tuberculosis
Incidence of tuberculosis over time
- Lesotho
- Myanmar
How they compare
Lesotho currently reports 548 per 100,000 people against 482 per 100,000 people in Myanmar, a difference of 66 per 100,000 people.
That makes Lesotho's figure about 1.1 times Myanmar's.
Across all 25 years both countries report, Lesotho has been ahead every year.
Lesotho ranks 4th and Myanmar ranks 7th of 208 countries.
Lesotho has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lesotho | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1,112 per 100,000 people | 544 per 100,000 people | 568 per 100,000 people | Lesotho |
| 2010s | 863.6 per 100,000 people | 404.9 per 100,000 people | 458.7 per 100,000 people | Lesotho |
| 2020s | 589.6 per 100,000 people | 413.4 per 100,000 people | 176.2 per 100,000 people | Lesotho |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher incidence of tuberculosis, Lesotho or Myanmar?
- Lesotho, at 548 per 100,000 people against 482 per 100,000 people in Myanmar as of 2024.
- What is the difference in incidence of tuberculosis between Lesotho and Myanmar?
- 66 per 100,000 people, with Lesotho ahead.
- How many years of comparable data are there for Lesotho and Myanmar?
- 25 years are reported by both, from 2000 to 2024.
- How do Lesotho and Myanmar rank globally for incidence of tuberculosis?
- Lesotho ranks 4th and Myanmar ranks 7th of 208 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Incidence of tuberculosis (per 100,000 people). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Incidence of tuberculosis is the estimated number of new and relapse tuberculosis cases arising in a given year, expressed as the rate per 100,000 population. All forms of TB are included, including cases in people living with HIV. Estimates for all years are recalculated as new information becomes available and techniques are refined, so they may differ from those published previously.